 |
2-chloro-N6-(3-iodobenzyl)adenosine-5′-N-methyluronamide |
|---|---|
| Trade Name | |
| Orphan Indication | Hepatocellular Carcinoma |
| EU Market Approval | EU |
| EU Designation Date | 2015-10-09 00:00:00 |
| Sponsor | PBS Regulatory Consulting Group Limited |
| |
2-chloro-N6-(3-iodobenzyl)adenosine-5′-N-methyluronamide |
|---|---|
| Trade Name | |
| Orphan Indication | Hepatocellular Carcinoma |
| EU Market Approval | EU |
| EU Designation Date | 2015-10-09 00:00:00 |
| Sponsor | PBS Regulatory Consulting Group Limited |